Author:
Fuchs Holger,Binder Rudolf,Greischel Andreas
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology,General Medicine
Reference17 articles.
1. 8-(3-(R)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356);Eckhardt;J Med Chem,2007
2. Incretins and other peptides in the treatment of diabetes;Todd;Diabet Med,2007
3. Enhancement or prolongation of GLP-1 activity as a strategy for treatment of type 2 diabetes;Ahrén;Drug Discov Today Ther Strategies,2004
4. Cell-surface peptidases;Mentlein;Int Rev Cytol,2004
5. R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazoli n-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors;Thomas;J Pharmacol Exp Ther,2008
Cited by
86 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献